Statistics in Biopharmaceutical Research

Scope & Guideline

Fostering interdisciplinary collaboration in biopharmaceutical statistics.

Introduction

Welcome to the Statistics in Biopharmaceutical Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Statistics in Biopharmaceutical Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1946-6315
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2011 to 2024
AbbreviationSTAT BIOPHARM RES / Stat. Biopharm. Res.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'Statistics in Biopharmaceutical Research' focuses on the application of statistical methodologies to enhance the design, analysis, and interpretation of biopharmaceutical research and clinical trials. It emphasizes innovative statistical techniques that address the complexities of modern biopharmaceutical studies, particularly in the context of regulatory requirements and real-world applications.
  1. Clinical Trial Design and Analysis:
    The journal extensively covers methodologies for designing and analyzing clinical trials, including adaptive designs, Bayesian approaches, and novel statistical frameworks that allow for more flexible and efficient trial processes.
  2. Real-World Evidence and Data Utilization:
    There is a significant emphasis on the integration of real-world data (RWD) and evidence (RWE) into statistical models for clinical trials, highlighting how such data can inform trial design, patient recruitment, and treatment efficacy assessments.
  3. Innovative Statistical Methodologies:
    The journal promotes the development and application of innovative statistical methodologies, including machine learning techniques, advanced modeling approaches, and Bayesian hierarchical models, to address specific challenges in biopharmaceutical research.
  4. Surrogate Endpoints and Biomarker Utilization:
    Research on surrogate endpoints and the use of biomarkers in clinical trials is a core area, focusing on how these tools can be effectively integrated into trial designs and analyses for better decision-making.
  5. Handling Missing Data and Censoring:
    The journal provides insights into modern techniques for handling missing data and censoring in clinical trials, emphasizing the importance of robust methodologies to ensure reliable conclusions.
  6. Multiplicity and Statistical Efficiency:
    A consistent focus is placed on addressing issues of multiplicity in clinical trials, developing strategies that balance statistical efficiency with the rigor required for regulatory compliance.
Recently, 'Statistics in Biopharmaceutical Research' has highlighted several emerging themes that reflect the current trends in the field. These themes showcase the journal's commitment to addressing contemporary challenges in biopharmaceutical statistics and improving clinical trial methodologies.
  1. Adaptive Trial Designs:
    There is a growing trend towards adaptive trial designs, which allow for modifications based on interim data. This reflects the industry's need for more flexible and efficient trial methodologies that can respond to real-time findings.
  2. Integration of Machine Learning Techniques:
    The incorporation of machine learning and artificial intelligence into biostatistics is increasingly prevalent, demonstrating the industry's shift towards leveraging advanced computational techniques for better data analysis and predictive modeling.
  3. Focus on Patient-Centric Approaches:
    Emerging research emphasizes patient-centric trial designs and analyses, considering patient preferences and outcomes, which is becoming crucial in the design of biopharmaceutical studies.
  4. Real-World Evidence and Data Science:
    The utilization of RWE and data science techniques is gaining traction, highlighting the importance of integrating observational data into clinical trial frameworks to enhance the relevance and applicability of research findings.
  5. Statistical Methods for Complex Multi-Arm Trials:
    There is an increasing focus on developing statistical methodologies tailored for complex multi-arm trials, which are common in oncology and other therapeutic areas, aiming to improve the efficiency of these studies.

Declining or Waning

As the field of biopharmaceutical research evolves, certain themes have seen a decline in publication frequency and relevance within the journal. This may reflect shifting priorities in research focus or advancements in statistical methodologies that render previous approaches less critical.
  1. Traditional Hypothesis Testing:
    There appears to be a waning interest in traditional hypothesis testing methods, particularly the use of p-values in favor of more nuanced approaches such as Bayesian methods and targeted learning frameworks.
  2. Fixed-Design Trials:
    The focus on fixed-design trials has diminished as adaptive and flexible trial designs gain prominence. Researchers are increasingly looking for methods that allow for modifications based on interim results.
  3. Single-Endpoint Analyses:
    There is a noticeable decrease in studies focusing solely on single endpoints in clinical trials. Instead, the trend is moving towards composite endpoints and multiple outcomes to capture the complexity of treatment effects.
  4. Conventional Statistical Models:
    The application of conventional statistical models without adaptation to current challenges in biopharmaceutical research is becoming less common, as the field demands more sophisticated and tailored approaches.

Similar Journals

Sankhya-Series B-Applied and Interdisciplinary Statistics

Advancing Applied Statistics for Tomorrow's Innovators
Publisher: SPRINGERISSN: 0976-8386Frequency: 2 issues/year

Sankhya-Series B: Applied and Interdisciplinary Statistics, published by Springer in India, serves as a vital platform for advancing the field of applied statistics and interdisciplinary research. With an ISSN of 0976-8386 and an E-ISSN of 0976-8394, this journal has made significant contributions since its inception in 2010, continuing to publish impactful research until 2024. The journal is ranked in the third quartile across several categories, including Applied Mathematics and Statistics, reflecting its importance within the academic community. Although not an open-access journal, Sankhya-Series B provides robust access options for its readership, facilitating the dissemination and discussion of critical statistical methodologies and applications. Researchers, professionals, and students are encouraged to engage with the journal's comprehensive scope, which includes a focus on statistical theory, methodologies, and their practical applications across various disciplines. By providing a rigorous forum for scholarly exchange, this journal plays an essential role in shaping the future of applied statistics and fostering interdisciplinary collaboration.

Sankhya-Series A-Mathematical Statistics and Probability

Elevating the Discourse in Probability and Statistical Methodologies
Publisher: SPRINGERISSN: 0976-836XFrequency: 2 issues/year

Sankhya-Series A-Mathematical Statistics and Probability is a prestigious academic journal published by SPRINGER, situated in the United States. With a focus on the rapidly evolving fields of mathematical statistics and probability, this journal serves as a critical platform for researchers, professionals, and students seeking to disseminate their findings and engage with latest advancements. Although it is not an open access publication, its rigorous peer-review process ensures high-quality content that contributes to the scholarly community. As of 2023, the journal is classified within the Q3 quartile in both Statistics and Probability, and Statistics, Probability and Uncertainty categories, reflecting its relevance and growing influence in the field. Sankhya-Series A showcases a convergence of interdisciplinary approaches, facilitating dialogue among statisticians and mathematicians, making it an essential resource for those committed to the exploration of theoretical and applied statistics. The journal accepts contributions advancing innovative research and methodologies, promoting a deeper understanding of probabilistic models and statistical techniques.

STATISTICAL METHODS IN MEDICAL RESEARCH

Advancing statistical innovation for better health outcomes.
Publisher: SAGE PUBLICATIONS LTDISSN: 0962-2802Frequency: 6 issues/year

STATISTICAL METHODS IN MEDICAL RESEARCH is a leading academic journal dedicated to advancing the field of statistical methodologies as they apply to medical research. Published by SAGE Publications Ltd, this prestigious journal focuses on innovative statistical techniques that are pivotal for health-related data analysis and interpretation. With its Q1 ranking in Epidemiology, Health Information Management, and Statistics and Probability as of 2023, it stands out as a vital resource for researchers and practitioners alike. The journal, which has been in circulation since 1992, is widely recognized for its robust contributions to evidence-based medicine and public health, ensuring that practitioners have access to cutting-edge research. Although it currently does not offer Open Access options, the high-impact nature indicated by its rankings and percentile positions solidifies its importance as a go-to source for statistical theories and applications in health research. Researchers, healthcare professionals, and students are encouraged to explore the rich content of this journal to stay abreast of the latest advancements and methodologies.

Statistics and Its Interface

Transforming Data into Knowledge Across Disciplines
Publisher: INT PRESS BOSTON, INCISSN: 1938-7989Frequency: 4 issues/year

Statistics and Its Interface, issn 1938-7989, published by INT PRESS BOSTON, INC, is a vital academic journal dedicated to bridging the critical intersection of statistics, applied mathematics, and interdisciplinary research. With its inaugural publication in 2011, this journal has continually aimed to provide a platform for innovative statistical methods and their application across various fields, offering valuable insights for researchers and practitioners alike. While the journal currently operates without an open access model, it maintains an essential position within the scholarly community, evidenced by its 2023 rankings in the third quartile for Applied Mathematics and the fourth quartile for Statistics and Probability. Furthermore, it holds a respectable position in Scopus rankings, reflecting its commitment to quality over quantity. By publishing cutting-edge research, Statistics and Its Interface serves as a critical resource for advancing statistical knowledge and cultivating a deeper understanding of its applications in real-world contexts.

Thailand Statistician

Exploring New Frontiers in Computational Mathematics
Publisher: THAI STATISTICAL ASSOCISSN: 1685-9057Frequency: 2 issues/year

Thailand Statistician, published by the THAI STATISTICAL ASSOCIATION, is a pivotal journal in the realms of computational mathematics and statistics. With an ISSN of 1685-9057 and an E-ISSN of 2351-0676, this journal aims to disseminate high-quality research and innovative methodologies that advance the fields of statistics and probability. Covering a range of topics from theoretical statistics to applied computational techniques, it provides a platform for researchers, professionals, and students in Thailand and beyond to contribute their findings and insights. The journal has been gaining recognition, boasting a Scopus ranking of Q3 in Computational Mathematics and Q4 in Statistics and Probability as of 2023. With its commitment to open access, the Thailand Statistician stands as an essential resource for those striving to stay abreast of advancements in statistical methodologies and their applications, fostering the growth of statistical science in the region and globally.

STATISTICS & PROBABILITY LETTERS

Fostering rigorous research for a deeper understanding of uncertainty.
Publisher: ELSEVIERISSN: 0167-7152Frequency: 12 issues/year

STATISTICS & PROBABILITY LETTERS is a distinguished journal published by ELSEVIER, dedicated to advancing the field of statistics and probability. With an ISSN of 0167-7152 and an E-ISSN of 1879-2103, this journal is an essential platform for research, featuring cutting-edge studies and significant findings in the realms of statistical theory and applied probability. The journal operates under a notable Q3 ranking in both the categories of Statistics and Probability, and Statistics, Probability and Uncertainty for 2023, underscoring its relevance in these fields. Researchers, professionals, and students alike benefit from its rigorous peer-review process and its commitment to published integrity, fostering innovative insights from 1982 through its anticipated convergence in 2025. While it does not offer open access, the journal’s widely recognized impact within the academic community makes it a valuable resource for anyone seeking to deepen their understanding of statistical methodologies and probabilistic models.

JOURNAL OF APPLIED STATISTICS

Bridging theory and practice in the world of statistics.
Publisher: TAYLOR & FRANCIS LTDISSN: 0266-4763Frequency: 12 issues/year

JOURNAL OF APPLIED STATISTICS, published by Taylor & Francis Ltd, is a prestigious scholarly resource that has been at the forefront of advancing the field of statistics since its inception in 1970. With ISSN 0266-4763 and E-ISSN 1360-0532, this esteemed journal focuses on the application of statistical methods across various disciplines, emphasizing practical implementations that provide significant insights into real-world problems. As a Q2 journal in both Statistics and Probability and Statistics, Probability and Uncertainty, it holds remarkable standings in Scopus, with ranks in the 77th and 74th percentiles, respectively. Researchers and professionals will find a wealth of rigorous methodologies and innovative analyses within its pages, aiming to bridge the gap between theory and practice. Although it adopts a traditional subscription model, its extensive archive—from 1970 to the present—offers invaluable resources for statisticians and data analysts. The journal serves as an essential platform for disseminating impactful research, making it a vital tool for students, researchers, and practitioners committed to the advancement of statistical science.

ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS

Exploring the Depths of Probability and Statistics
Publisher: SPRINGER HEIDELBERGISSN: 0020-3157Frequency: 5 issues/year

ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS, published by SPRINGER HEIDELBERG, is a prestigious academic journal that has played a pivotal role in the field of statistical mathematics since its inception in 1949. With a focus on advancing research in statistics and probability, this journal is ranked in the Q2 quartile for 2023, indicating its significance and impact within the academic community. Researchers and professionals engaged in statistical theory and methodology will find the journal's comprehensive coverage of contemporary issues essential for furthering their work and understanding of the discipline. The journal is accessible in print and digital formats, facilitating wide dissemination of knowledge among its readership. With a history of rigorous peer review and a commitment to high-quality research, the ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS continues to be a vital resource for academics and practitioners alike.

PHARMACEUTICAL STATISTICS

Empowering Research with Statistical Insights in Pharmacology
Publisher: WILEYISSN: 1539-1604Frequency: 6 issues/year

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

Pakistan Journal of Statistics and Operation Research

Transforming Data into Decisions
Publisher: UNIV PUNJABISSN: 1816-2711Frequency: 4 issues/year

The Pakistan Journal of Statistics and Operation Research is an esteemed academic publication dedicated to the fields of statistics, operations research, and their applications. Published by University of Punjab, this journal features innovative research that contributes significantly to the advancement of knowledge in Management Science, Modeling and Simulation, and Statistics and Probability. With an impressive Scopus ranking and categorized in Q2 and Q3 quartiles, it actively disseminates high-quality findings in these critical areas of study, making it an essential resource for researchers, professionals, and students seeking to enhance their understanding and application of statistical methodologies and operational frameworks. Although it is primarily published in Pakistan, the journal’s influence is recognized internationally, encouraging a global perspective on complex statistical challenges. With its convergence years spanning from 2011 to 2024, readers can expect a continual flow of cutting-edge research and practical insights that address the evolving demands of the field.